In the past week, CVS stock has gone down by -0.88%, with a monthly decline of -5.56% and a quarterly plunge of -20.78%. The volatility ratio for the week is 1.58%, and the volatility levels for the last 30 days are 1.79% for CVS Health Corporation The simple moving average for the past 20 days is -2.03% for CVS’s stock, with a -22.83% simple moving average for the past 200 days.
Is It Worth Investing in CVS Health Corporation (NYSE: CVS) Right Now?
CVS Health Corporation (NYSE: CVS) has a price-to-earnings ratio of 22.68x that is above its average ratio. Additionally, the 36-month beta value for CVS is 0.61. There are mixed opinions on the stock, with 15 analysts rating it as a “buy,” 2 rating it as “overweight,” 8 rating it as “hold,” and 0 rating it as “sell.”
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
The average price predicted by analysts for CVS is $98.75, which is $32.13 above the current price. The public float for CVS is 1.28B and currently, short sellers hold a 1.32% ratio of that float. The average trading volume of CVS on May 25, 2023 was 8.49M shares.
CVS) stock’s latest price update
The stock price of CVS Health Corporation (NYSE: CVS) has plunged by -1.22 when compared to previous closing price of 69.67, but the company has seen a -0.88% decline in its stock price over the last five trading sessions. The Wall Street Journal reported on 05/03/23 that CVS Posts Higher Revenue as Acquisitions Close
CVS Trading at -5.73% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.84% of loss for the given period.
Volatility was left at 1.79%, however, over the last 30 days, the volatility rate increased by 1.58%, as shares sank -4.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.92% lower at present.
During the last 5 trading sessions, CVS fell by -0.88%, which changed the moving average for the period of 200-days by -32.53% in comparison to the 20-day moving average, which settled at $70.07. In addition, CVS Health Corporation saw -26.15% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from Lynch Karen S, who purchase 14,000 shares at the price of $69.75 back on May 03. After this action, Lynch Karen S now owns 431,392 shares of CVS Health Corporation, valued at $976,567 using the latest closing price.
Moriarty Thomas M, the EVP & General Counsel of CVS Health Corporation, sale 137,466 shares at $98.36 during a trade that took place back on Dec 15, which means that Moriarty Thomas M is holding 608,129 shares at $13,521,180 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- +5.08 for the present operating margin
- +16.92 for the gross margin
The net margin for CVS Health Corporation stands at +1.29. The total capital return value is set at 11.18, while invested capital returns managed to touch 2.93. Equity return is now at value 5.50, with 1.70 for asset returns.
Based on CVS Health Corporation (CVS), the company’s capital structure generated 99.60 points at debt to equity in total, while total debt to capital is 49.90. Total debt to assets is 29.94, with long-term debt to equity ratio resting at 94.73. Finally, the long-term debt to capital ratio is 47.46.
When we switch over and look at the enterprise to sales, we see a ratio of 0.44, with the company’s debt to enterprise value settled at 0.40. The receivables turnover for the company is 12.49 and the total asset turnover is 1.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
In conclusion, CVS Health Corporation (CVS) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
